(Q34049805)

30 July 2017

0 references

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori (English)

1 reference

Helicobacter pylori infectious disease

30 July 2017

0 references

0 references

1 reference

1 reference

1 reference

J P Gisbert

1

1 reference

30 July 2017

L González

2

1 reference

30 July 2017

X Calvet

3

1 reference

30 July 2017

N García

4

1 reference

30 July 2017

T López

5

1 reference

30 July 2017

M Roqué

6

1 reference

30 July 2017

R Gabriel

7

1 reference

30 July 2017

J M Pajares

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Alimentary Pharmacology & Therapeutics

30 July 2017

published in

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

1319-1328

1 reference

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Clinical relevance of resistant strains of Helicobacter pylori: a review of current data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Ranitidine bismuth citrate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00844.X

10.1046/J.1365-2036.2000.00844.X

21 January 2018

Identifiers

DOI

1 reference

release_vuagte4vu5hclnl6vpg3gigw3m

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vuagte4vu5hclnl6vpg3gigw3m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference